查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2138140

泡殼包裝和翻蓋包裝藥品市場預測至2034年－按產品類型、包裝類型、材料、分銷管道、技術、最終用戶和地區分類的全球分析

Blister & Clamshell Pharmaceutical Packaging Market Forecasts to 2034 - Global Analysis By Product Type, Packaging Type, Material, Distribution Channel, Technology, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 預測，全球泡殼包裝和翻蓋包裝藥品市場預計將在 2026 年達到 75 億美元，並在預測期內以 4.8% 的複合年成長率成長，到 2034 年達到 110 億美元。

泡殼包裝和翻蓋式包裝為藥品保護、清晰展示和使用提供了可靠的方法。泡殼包裝將片劑、膠囊或單劑量藥品封裝在模製隔間內，並用背襯層密封，有助於維持產品品質並簡化藥品管理。翻蓋式包裝則將藥品包裹在堅硬透明的塑膠中，確保產品在搬運過程中清晰可見並受到保護。這些包裝方案有助於防止污染、增強防篡改能力、提高便利性並維護藥品的完整性。其靈活的結構使其適用於各種應用場景，包括藥房、醫院、零售通路和處方藥分銷。

據美國食品藥物管理局（FDA）稱，其藥品評估與研究中心每年收到超過30萬份申請，其中包括數百萬條與人用藥品和生物製藥相關的數據。這顯示製藥業的規模龐大，監管活動也十分活躍，支撐了對合規包裝的持續需求。

對單劑量和對象患者使用的包裝的需求不斷成長。

消費者對便利、以病人為中心的單劑量藥物包裝的需求日益成長，推動了泡殼包裝和翻蓋包裝的普及。泡殼包裝將藥物以劑量分隔，使患者更容易遵醫囑服藥，同時盡量減少用藥錯誤。其輕巧緊湊的設計也便於儲存、搬運和配送。翻蓋包裝在提供有效物理保護的同時，還能保持產品可見性，並可依特定藥物應用進行客製化。因此，人們對用藥安全、便利性和高效分發的日益關注，促使製藥公司和經銷商更廣泛地採用這些包裝形式。

包裝材料和製造成本高昂

原料和製造成本的上漲可能會阻礙泡殼包裝和翻蓋包裝藥品市場的擴張。這些包裝形式可能需要專門的設備和工藝來進行成型、密封、印刷、檢測和品質保證，這可能會增加生產成本。使用先進的阻隔材料和硬質塑膠也會增加製藥企業的額外支出。因此，成本控制嚴格的公司可能會考慮成本較低的替代包裝。此外，能源、原料、機械和人事費用的上漲可能會進一步增加藥品包裝預算的壓力。

開發永續的吸塑包裝和翻蓋包裝

人們對環保泡殼包裝和翻蓋包裝日益成長的興趣帶來了巨大的市場機會。製藥公司正在尋求既能充分保護藥品，又能減少材料用量、提高可回收性並實現永續性目標的包裝。包裝製造商可以透過開發可回收聚合物、纖維基材料、單一材料解決方案和輕質結構來滿足這些需求。優先發展永續包裝的企業能夠使其產品脫穎而出，響應不斷變化的客戶偏好，並幫助製藥公司實現其環境目標。

與替代藥品包裝形式的競爭

替代藥品包裝解決方案的日益普及對泡殼包裝和翻蓋包裝的需求構成潛在威脅。瓶裝、袋裝、小袋裝、管裝和軟包裝為生產商提供了多種選擇，以控制成本、包裝體積、劑量和材料消耗。包裝技術的持續創新可能會促使製藥公司選擇更適合特定藥物和供應鏈的包裝形式。這些替代包裝形式的競爭加劇可能會導致泡殼包裝和翻蓋包裝的採用率下降，同時包裝生產商也面臨更大的壓力，需要提高產品的功能性、便利性、永續性和永續性。

新型冠狀病毒（COVID-19）的影響：

新冠疫情對泡殼包裝和翻蓋包裝藥品市場產生了正面和負面的雙重影響。疫情期間，藥品、疫苗和基本醫療產品的需求激增，帶動了包裝需求的成長。然而，封鎖措施、物流限制、人手不足和供應鏈中斷也給製造商帶來了挑戰，導致關鍵原料採購延遲。隨著藥品生產和醫療運作逐漸恢復正常，市場需求也隨之復甦。此外，疫情也促使人們更加關注衛生、安全、防竄改和便利的單劑量藥品包裝。

在預測期內，固態劑型細分市場預計將佔據最大的市場佔有率。

預計在預測期內，固態劑型將佔據最大的市場佔有率。這是因為片劑和膠囊通常是用泡殼包裝或翻蓋包裝。泡殼包裝尤其適用於單一劑量固態藥物，可實現劑量分離、防止污染並方便給藥。其結構也便於辨識已使用和未使用劑量，幫助患者管理用藥方案。製藥公司廣泛採用這些包裝形式，因為它們能夠有效平衡藥物保護、便利性、便攜性、簡化的劑量管理以及在整個醫療保健供應和分銷管道中的實用性。

在預測期內，營養保健品產業預計將呈現最高的複合年成長率。

在預測期內，受膳食補充劑、維生素和健康相關產品消費成長的推動，營養補充品領域預計將呈現最高的成長率。泡殼包裝可提供個人化的劑量控制、便利的操作以及免受環境影響的保護，而翻蓋包裝則具備營養補充劑所需的強度和清晰的產品展示效果。隨著消費者對預防性健康維護和營養支援的日益關注，製造商對可靠且易於使用的包裝提出了更高的要求。隨著營養保健品種類的不斷豐富，對能夠在整個分銷管道中提供便利性、保護性和有效產品展示的包裝形式的需求也日益成長。

市佔率最大的地區：

在預測期內，亞太地區預計將佔據最大的市場佔有率，這主要得益於該地區大規模的藥品生產、醫療保健體系的完善以及藥品消費量的成長。該地區的許多製藥企業都依賴可靠的包裝來包裝片劑、膠囊、醫療產品及相關醫療保健產品。醫療保健領域的投資增加、藥品可近性的提高以及藥品供應鏈網路的完善，都支撐著對包裝的需求。此外，該地區成熟的包裝供應商和不斷擴大的生產能力，也促進了泡殼包裝和翻蓋包裝解決方案在醫療保健市場的廣泛應用。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於新興經濟體藥品生產規模的擴大、醫療保健支出的成長以及藥品消費量的成長。對醫療保健基礎設施和生產能力的投資催生了對安全便捷包裝的需求。單劑量製劑和藥品分銷系統的普及，以及對藥品安全性的日益重視，都支撐了這項需求。該地區學名藥行業的擴張和醫療保健服務的改善，正在推動泡殼包裝和翻蓋包裝的普及。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球泡殼包裝與翻蓋包裝藥品市場：依產品類型分類

  • 固態劑量
  • 液體
  • 醫療設備及配件

第6章 全球泡殼包裝與翻蓋包裝藥品市場：依包裝類型分類

  • 吸塑包裝
  • 翻蓋式包裝

第7章 全球泡殼包裝與翻蓋式藥品包裝市場：依材料分類

  • 塑膠
    • PVC
    • PET
    • PP
    • PE
  • 鋁
  • 紙板

第8章 全球泡殼包裝與翻蓋包裝藥品市場：依通路分類

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第9章 全球泡殼和翻蓋式藥品包裝市場：依技術分類

  • 冷成型
  • 熱成型

第10章 全球泡殼包裝與翻蓋式藥品包裝市場：依最終用戶分類

  • 製藥
  • 營養保健品
  • 醫療器材

第11章 全球泡殼包裝與翻蓋包裝藥品市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Amcor plc
  • Gerresheimer AG
  • Sonoco Products Company
  • WestRock Company
  • Constantia Flexibles
  • Klockner Pentaplast
  • Tekni-Plex, Inc.
  • West Pharmaceutical Services, Inc.
  • AptarGroup, Inc.
  • Huhtamaki Oyj
  • Uflex Limited
  • Rohrer Corporation
  • Placon Corporation
  • ACG
  • Winpak Ltd.
  • Bilcare Limited
  • Svam Toyal Packaging Industries
  • VisiPak Inc.
Product Code: SMRC39739

According to Stratistics MRC, the Global Blister & Clamshell Pharmaceutical Packaging Market is accounted for $7.5 billion in 2026 and is expected to reach $11.0 billion by 2034 growing at a CAGR of 4.8% during the forecast period. Blister and clamshell pharmaceutical packaging offers reliable methods for protecting, presenting, and dispensing medicines. Blister formats contain tablets, capsules, or individual doses within molded compartments sealed by a backing layer, helping maintain product quality and simplify medication management. Clamshell formats surround pharmaceutical products with rigid, transparent plastic, providing product visibility and protection during handling. These packaging solutions can limit contamination, support tamper resistance, improve convenience, and maintain medicine integrity. Their adaptable construction enables use across pharmacies, hospitals, retail channels, and prescription drug distribution.

According to the FDA, its Center for Drug Evaluation and Research receives more than 300,000 submissions annually, representing millions of pieces of data associated with human drug and biologic products. This indicates the substantial scale and regulatory activity of the pharmaceutical sector supporting continued requirements for compliant packaging.

Market Dynamics:

Driver:

Growing demand for unit-dose and patient-friendly packaging

Increasing preference for convenient, patient-oriented, and unit-dose pharmaceutical packaging is supporting the adoption of blister and clamshell formats. Blister packs can separate medicines into individual doses, enabling patients to follow prescribed schedules more easily while helping minimize medication mistakes. Their lightweight and compact construction also facilitates storage, handling, and distribution. Clamshell packaging offers strong physical protection together with product visibility, supporting specific pharmaceutical applications. Growing attention toward medication safety, convenience, and efficient dispensing is therefore encouraging pharmaceutical companies and distributors to use these packaging formats more widely.

Restraint:

High packaging material and production costs

Elevated material and manufacturing expenses may limit expansion of the blister and clamshell pharmaceutical packaging market. These packaging formats can require specialized equipment and processes for forming, molding, sealing, printing, inspection, and quality assurance, which can increase production costs. The use of advanced barrier materials and rigid plastics may add further expense for pharmaceutical manufacturers. Companies operating under strict cost constraints may therefore evaluate less expensive packaging alternatives. In addition, increasing prices for energy, raw materials, machinery, and labor can place additional pressure on pharmaceutical packaging budgets.

Opportunity:

Development of sustainable blister and clamshell packaging

Growing interest in environmentally responsible blister and clamshell pharmaceutical packaging offers substantial opportunities for market development. Drug manufacturers are looking for formats that lower material usage, enhance recyclability, and meet sustainability goals while maintaining adequate protection for medicines. Packaging producers can respond by developing recyclable polymers, fiber-based components, mono-material solutions, and lightweight constructions. Businesses that prioritize sustainable packaging development can differentiate their offerings, respond to changing customer preferences, and support pharmaceutical companies in achieving environmental targets.

Threat:

Competition from alternative pharmaceutical packaging formats

The growing availability of alternative pharmaceutical packaging solutions represents a potential threat to blister and clamshell packaging demand. Bottles, pouches, sachets, tubes, and flexible formats provide manufacturers with various options for controlling costs, packaging volumes, dispensing methods, and material consumption. Continued innovation in packaging technologies may encourage pharmaceutical companies to choose formats better suited to particular medicines and supply chains. Greater competition from these alternatives could reduce the adoption of blister and clamshell formats while increasing pressure on packaging manufacturers to deliver improved functionality, convenience, sustainability, and affordability.

Covid-19 Impact:

The COVID-19 outbreak produced both positive and negative effects on the blister and clamshell pharmaceutical packaging market. Higher requirements for medicines, vaccines, and critical healthcare products increased packaging demand during the pandemic. Conversely, lockdown measures, logistics limitations, workforce shortages, and disrupted supply chains created challenges for manufacturers and delayed access to essential materials. With pharmaceutical manufacturing and healthcare operations gradually normalizing, market demand improved. The pandemic additionally increased emphasis on hygienic, secure, tamper-resistant, and convenient unit-dose pharmaceutical packaging.

The solid dosage forms segment is expected to be the largest during the forecast period

The solid dosage forms segment is expected to account for the largest market share during the forecast period because tablets and capsules are commonly packed in blister and clamshell formats. Blister packs are especially appropriate for individual solid medicines, offering separated doses, protection against contamination, and simple dispensing. Their structure can help patients manage medication schedules by making used and unused doses easily identifiable. Pharmaceutical producers widely use these formats because they provide an effective balance of medicine protection, convenience, portability, organized dosing, and practical handling throughout healthcare supply and distribution channels.

The nutraceuticals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the nutraceuticals segment is predicted to witness the highest growth rate, driven by rising consumption of dietary supplements, vitamins, and wellness-focused products. Blister packaging supports separated doses, easy handling, and protection against environmental exposure, while clamshell packaging offers strength and clear product presentation for suitable nutraceutical applications. Increasing consumer focus on preventive wellness and nutritional support is prompting manufacturers to seek dependable and user-friendly packaging. As nutraceutical product ranges expand, demand is growing for packaging formats that provide convenience, protection, and efficient product presentation across distribution channels.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to its extensive pharmaceutical production, improving healthcare systems, and increasing consumption of medicines. Numerous pharmaceutical manufacturers across the region depend on dependable packaging for tablets, capsules, medical products, and related healthcare applications. Expanding healthcare investments, greater medicine availability, and developing pharmaceutical supply networks are supporting packaging demand. The region also benefits from established packaging suppliers and expanding manufacturing capabilities, which are encouraging broader use of blister and clamshell packaging solutions across healthcare markets.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, supported by expanding drug production, increasing healthcare spending, and rising pharmaceutical consumption across developing economies. Investments in medical infrastructure and manufacturing capacity are generating requirements for secure, convenient packaging. Wider use of unit-dose formats, medicine distribution systems, and stronger emphasis on pharmaceutical safety support demand. The region's expanding generic medicines industry and improving healthcare access are encouraging adoption of blister and clamshell packaging.

Key players in the market

Some of the key players in Blister & Clamshell Pharmaceutical Packaging Market include Amcor plc, Gerresheimer AG, Sonoco Products Company, WestRock Company, Constantia Flexibles, Klockner Pentaplast, Tekni-Plex, Inc., West Pharmaceutical Services, Inc., AptarGroup, Inc., Huhtamaki Oyj, Uflex Limited, Rohrer Corporation, Placon Corporation, ACG, Winpak Ltd., Bilcare Limited, Svam Toyal Packaging Industries and VisiPak Inc.

Key Developments:

In July 2026, Sonoco Products Company announced continued investment to expand its Wood Reels manufacturing and assembly footprint to meet a surge in demand for power and communications cable packaging driven by AI data center growth and power grid modernization.

In April 2025, Amcor plc announced the successful completion of its all-stock combination with Berry Global, effective. Through this combination, Amcor enhances its position as a global leader in consumer and healthcare packaging solutions with the unique material science and innovation capabilities required to revolutionize product development and meet customers' and consumers' sustainability aspirations.

Product Types Covered:

  • Solid Dosage Forms
  • Liquid Dosage Forms
  • Medical Devices & Accessories

Packaging Types Covered:

  • Blister Packaging
  • Clamshell Packaging

Materials Covered:

  • Plastic
  • Aluminum
  • Paperboard

Distribution Channels Covered:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Technologies Covered:

  • Cold Forming
  • Thermoforming

End Users Covered:

  • Pharmaceuticals
  • Nutraceuticals
  • Medical Devices

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Blister & Clamshell Pharmaceutical Packaging Market, By Product Type

  • 5.1 Solid Dosage Forms
  • 5.2 Liquid Dosage Forms
  • 5.3 Medical Devices & Accessories

6 Global Blister & Clamshell Pharmaceutical Packaging Market, By Packaging Type

  • 6.1 Blister Packaging
  • 6.2 Clamshell Packaging

7 Global Blister & Clamshell Pharmaceutical Packaging Market, By Material

  • 7.1 Plastic
    • 7.1.1 PVC
    • 7.1.2 PET
    • 7.1.3 PP
    • 7.1.4 PE
  • 7.2 Aluminum
  • 7.3 Paperboard

8 Global Blister & Clamshell Pharmaceutical Packaging Market, By Distribution Channel

  • 8.1 Hospital Pharmacies
  • 8.2 Retail Pharmacies
  • 8.3 Online Pharmacies

9 Global Blister & Clamshell Pharmaceutical Packaging Market, By Technology

  • 9.1 Cold Forming
  • 9.2 Thermoforming

10 Global Blister & Clamshell Pharmaceutical Packaging Market, By End User

  • 10.1 Pharmaceuticals
  • 10.2 Nutraceuticals
  • 10.3 Medical Devices

11 Global Blister & Clamshell Pharmaceutical Packaging Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Amcor plc
  • 14.2 Gerresheimer AG
  • 14.3 Sonoco Products Company
  • 14.4 WestRock Company
  • 14.5 Constantia Flexibles
  • 14.6 Klockner Pentaplast
  • 14.7 Tekni-Plex, Inc.
  • 14.8 West Pharmaceutical Services, Inc.
  • 14.9 AptarGroup, Inc.
  • 14.10 Huhtamaki Oyj
  • 14.11 Uflex Limited
  • 14.12 Rohrer Corporation
  • 14.13 Placon Corporation
  • 14.14 ACG
  • 14.15 Winpak Ltd.
  • 14.16 Bilcare Limited
  • 14.17 Svam Toyal Packaging Industries
  • 14.18 VisiPak Inc.

List of Tables

  • Table 1 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By Solid Dosage Forms (2023-2034) ($MN)
  • Table 4 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By Liquid Dosage Forms (2023-2034) ($MN)
  • Table 5 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By Medical Devices & Accessories (2023-2034) ($MN)
  • Table 6 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By Packaging Type (2023-2034) ($MN)
  • Table 7 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By Blister Packaging (2023-2034) ($MN)
  • Table 8 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By Clamshell Packaging (2023-2034) ($MN)
  • Table 9 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By Material (2023-2034) ($MN)
  • Table 10 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By Plastic (2023-2034) ($MN)
  • Table 11 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By PVC (2023-2034) ($MN)
  • Table 12 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By PET (2023-2034) ($MN)
  • Table 13 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By PP (2023-2034) ($MN)
  • Table 14 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By PE (2023-2034) ($MN)
  • Table 15 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By Aluminum (2023-2034) ($MN)
  • Table 16 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By Paperboard (2023-2034) ($MN)
  • Table 17 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 18 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By Hospital Pharmacies (2023-2034) ($MN)
  • Table 19 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 20 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By Online Pharmacies (2023-2034) ($MN)
  • Table 21 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By Technology (2023-2034) ($MN)
  • Table 22 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By Cold Forming (2023-2034) ($MN)
  • Table 23 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By Thermoforming (2023-2034) ($MN)
  • Table 24 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By End User (2023-2034) ($MN)
  • Table 25 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By Pharmaceuticals (2023-2034) ($MN)
  • Table 26 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By Nutraceuticals (2023-2034) ($MN)
  • Table 27 Global Blister & Clamshell Pharmaceutical Packaging Market Outlook, By Medical Devices (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.